Our analysis showed that RRM2 was not only significantly upregulated in NSCLC patients compared with healthy controls, but also that the serum RRM2 levels in NSCLC patients were associated with distant metastasis and histological type, but not with tumor size or lymph node metastasis. The gene discussed is RRM2; the disease is non-small cell lung carcinoma.